Osprey Pharmaceuticals USA, Inc. Report issue

For profit Phase 1
Founded: San Francisco CA United States (1998)
Status: Acquired by CoMentis (2006)

Organization Overview

First Clinical Trial
2009
NCT00856674
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (1)

opl-ccl2-lpm (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis, IGA (Phase 1)

Kidney Diseases (Phase 1)

Proteinuria (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1